Literature DB >> 25571788

Natural killer cells: In health and disease.

Arundhati Mandal1, Chandra Viswanathan2.   

Abstract

Natural killer (NK) cells constitute our bodies' frontline defense system, guarding against tumors and launching attacks against infections. The activities of NK cells are regulated by the interaction of various receptors expressed on their surfaces with cell surface ligands. While the role of NK cells in controlling tumor activity is relatively clear, the fact that they are also linked to various other disease conditions is now being highlighted. Here, we present an overview of the role of NK cells during normal body state as well as under diseased state. We discuss the possible utilization of these powerful cells as immunotherapeutic agents in combating diseases such as asthma, autoimmune diseases, and HIV-AIDS. This review also outlines current challenges in NK cell therapy.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Immunotherapy; NK cells and HIV1; NK cells and autoimmunity; NK cells and cancer; Natural killer (NK) cells

Mesh:

Year:  2014        PMID: 25571788     DOI: 10.1016/j.hemonc.2014.11.006

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  84 in total

1.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

Review 2.  (Putative) sex differences in neuroimmune modulation of memory.

Authors:  Natalie C Tronson; Katie M Collette
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  The Expression of Activating Receptor Gene of Natural Killer Cells (KLRC3) in Patients with 
Type 1 Diabetes Mellitus (T1DM).

Authors:  Dalia Shalaby; Marwa Saied; Doaa Khater; Abla Abou Zeid
Journal:  Oman Med J       Date:  2017-07

Review 4.  Host immune cellular reactions in corneal neovascularization.

Authors:  Nizar S Abdelfattah; Mohamed Amgad; Amira A Zayed
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

5.  Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques.

Authors:  Diego A Vargas-Inchaustegui; Sabrina Helmold Hait; Hye Kyung Chung; Jigna Narola; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

6.  A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.

Authors:  Fadi Kandarian; Gemalene M Sunga; Diana Arango-Saenz; Maura Rossetti
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

7.  Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Authors:  Corbin A Shields; Maggie McCalmon; Tarek Ibrahim; Dakota L White; Jan M Williams; Babbette LaMarca; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-02       Impact factor: 3.619

8.  Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

Authors:  Lucas Souza Ferreira; Deivys Leandro Portuondo; Marisa Campos Polesi; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2018-08-14       Impact factor: 7.397

9.  Secretory TRAIL-Armed Natural Killer Cell-Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft.

Authors:  Xinxin Song; Se-Hoon Hong; William T Kwon; Lisa M Bailey; Per Basse; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Mol Cancer Ther       Date:  2016-04-12       Impact factor: 6.261

Review 10.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.